Clinical Applications of Transcranial Magnetic Stimulation: A Canadian Guide
Approximately 33% of Canadian patients diagnosed with major depressive disorder don’t achieve remission after standard antidepressant trials and…
Mastering TMS: The MagVenture Accelerator Training Path for Canadian Clinicians
With rTMS showing remission rates of 30-35% in patients with medically refractory depression, the difference between clinical success and stalled…